Journal of Cancer Therapy

Vol.9 No.12(2018), Paper ID 89196, 13 pages

DOI:10.4236/jct.2018.912082

 

Treatment Outcome of Pharmacokinetics-Based Dosing of Docetaxel and Fluorouracil in Advanced Head and Neck Cancer Patients

 

Abdelhamid M. Fouad, Magdy M. Saber, Yahia M. Ismail, Yasser A. Sallam, Tarek M. Shouman, Reham A. A. Elshimy, Ahmed Abo Gabal

 

Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Clinical and Chemical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo, Egypt

 

Copyright © 2018 Abdelhamid M. Fouad, Magdy M. Saber, Yahia M. Ismail, Yasser A. Sallam, Tarek M. Shouman, Reham A. A. Elshimy, Ahmed Abo Gabal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Fouad, A. , Saber, M. , Ismail, Y. , Sallam, Y. , Shouman, T. , Elshimy, R. and Gabal, A. (2018) Treatment Outcome of Pharmacokinetics-Based Dosing of Docetaxel and Fluorouracil in Advanced Head and Neck Cancer Patients. Journal of Cancer Therapy, 9, 998-1010. doi: 10.4236/jct.2018.912082.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.